Simeprevir

Results: 32



#Item
11FEUILLET D’INFORMATION Le siméprévir (Galexos) Sommaire Le siméprévir est un médicament utilisé pour le traitement de l’hépatite C. Il est prescrit en combinaison avec d’autres

FEUILLET D’INFORMATION Le siméprévir (Galexos) Sommaire Le siméprévir est un médicament utilisé pour le traitement de l’hépatite C. Il est prescrit en combinaison avec d’autres

Add to Reading List

Source URL: librarypdf.catie.ca

Language: French - Date: 2014-12-08 17:37:27
    12FACTSHEET Simeprevir (Galexos) Summary Simeprevir is a medication used to treat Hep C. It is used in combination with other medications to cure people of the Hep C

    FACTSHEET Simeprevir (Galexos) Summary Simeprevir is a medication used to treat Hep C. It is used in combination with other medications to cure people of the Hep C

    Add to Reading List

    Source URL: librarypdf.catie.ca

    Language: English - Date: 2014-12-08 17:37:28
    13FEUILLET D’INFORMATION Le siméprévir (Galexos) Sommaire Le siméprévir est un médicament utilisé pour le traitement de l’hépatite C. Il est prescrit en combinaison avec d’autres

    FEUILLET D’INFORMATION Le siméprévir (Galexos) Sommaire Le siméprévir est un médicament utilisé pour le traitement de l’hépatite C. Il est prescrit en combinaison avec d’autres

    Add to Reading List

    Source URL: www.catie.ca

    Language: French
      14FACTSHEET Simeprevir (Galexos) Summary Simeprevir is a medication used to treat Hep C. It is used in combination with other medications to cure people of the Hep C

      FACTSHEET Simeprevir (Galexos) Summary Simeprevir is a medication used to treat Hep C. It is used in combination with other medications to cure people of the Hep C

      Add to Reading List

      Source URL: www.catie.ca

      Language: English
      15Simeprevir Sodium and Hyperbilirubinaemia Details of 3 cases of hyperbilirubinaemia with use of simeprevir sodium are shown below. (This information has been posted on the website prior to the publication of the English

      Simeprevir Sodium and Hyperbilirubinaemia Details of 3 cases of hyperbilirubinaemia with use of simeprevir sodium are shown below. (This information has been posted on the website prior to the publication of the English

      Add to Reading List

      Source URL: www.pmda.go.jp

      Language: English - Date: 2014-11-25 02:54:11
      16NC Division of Medical Assistance Outpatient Pharmacy Prior Approval Criteria Olysio (simeprevir) Medicaid and Health Choice

      NC Division of Medical Assistance Outpatient Pharmacy Prior Approval Criteria Olysio (simeprevir) Medicaid and Health Choice

      Add to Reading List

      Source URL: www.ncdhhs.gov

      Language: English - Date: 2014-12-19 12:26:05
      17HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OLYSIOTM safely and effectively. See full prescribing information for OLYSIO. OLYSIO (simeprevir) capsules, for oral

      HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OLYSIOTM safely and effectively. See full prescribing information for OLYSIO. OLYSIO (simeprevir) capsules, for oral

      Add to Reading List

      Source URL: www.accessdata.fda.gov

      Language: English - Date: 2014-09-09 11:11:46
      18Genotype 1: Olysio (Simeprevir) PlusPegylated Interferon & Ribavirin

      Genotype 1: Olysio (Simeprevir) PlusPegylated Interferon & Ribavirin

      Add to Reading List

      Source URL: www.hcvadvocate.org

      Language: English - Date: 2014-09-18 02:19:18
      19Genotype 1 Treatment: Olysio (Simeprevir) A new drug combination was recently approved by the Food and Drug Administration. The new

      Genotype 1 Treatment: Olysio (Simeprevir) A new drug combination was recently approved by the Food and Drug Administration. The new

      Add to Reading List

      Source URL: www.hcvadvocate.org

      Language: English - Date: 2014-09-18 02:04:44
      20HEP[removed]Revised Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 HCV in interferon ineligible/intolerant individuals Liesl M. Hagan1, Mark S. Sulkowski2, Raymond F. Schinazi1

      HEP[removed]Revised Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 HCV in interferon ineligible/intolerant individuals Liesl M. Hagan1, Mark S. Sulkowski2, Raymond F. Schinazi1

      Add to Reading List

      Source URL: www.natap.org

      Language: English - Date: 2014-04-03 14:47:15